Evidence map›Paper›PMID 30232098›Full record

ArticleOpen biology2018

Reduction of leucocyte cell surface disulfide bonds during immune activation is dynamic as revealed by a quantitative proteomics workflow (SH-IQ).

Monika Stegmann, A Neil Barclay, Clive Metcalfe

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Monika StegmannThe Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
A Neil BarclayThe Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Clive MetcalfeThe Sir William Dunn School of Pathology, University of Oxford, Oxford, UK clive.metcalfe@nibsc.org.ORCID 0000-0002-7856-8574
University of Oxford · GB

Funding

Medical Research Council G9826026
6 · The paper itself

Abstract

Communication through cell surface receptors is crucial for maintaining immune homeostasis, coordinating the immune response and pathogen clearance. This is dependent on the interaction of cell surface receptors with their ligands and requires functionally active conformational states. Thus, immune cell function can be controlled by modulating the structure of either the receptor or the ligand. Reductive cleavage of labile disulfide bonds can mediate such an allosteric change, resulting in modulation of the immune system by a hitherto little studied mechanism. Identifying proteins with labile disulfide bonds and determining the extent of reduction is crucial in elucidating the functional result of reduction. We describe a mass spectrometry-based method-thiol identification and quantitation (SH-IQ)-to identify, quantify and monitor such reduction of labile disulfide bonds in primary cells during immune activation. These results provide the first insight into the extent and dynamics of labile disulfide bond reduction in leucocyte cell surface proteins upon immune activation. We show that this process is thiol oxidoreductase-dependent and mainly affects activatory (e.g. CD132, SLAMF1) and adhesion (CD44, ICAM1) molecules, suggesting a mechanism to prevent over-activation of the immune system and excessive accumulation of leucocytes at sites of inflammation.

Indexed as

Cells, CulturedDisulfidesHumansImmune SystemLeukocytesMass SpectrometryMembrane ProteinsModels, MolecularOxidation-ReductionPhosphinesProtein ConformationProtein Disulfide Reductase (Glutathione)ProteomicsWorkflowDisulfidesMembrane ProteinsPhosphinesProtein Disulfide Reductase (Glutathione)tris(2-carboxyethyl)phosphineallosteric disulfide bondsimmune receptorsimmune regulationproteomicsredox regulationthioredoxin

Identifiers

PMID30232098
PMCPMC6170505
OpenAlexW2891029793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.